Xconomy National

Archives

by in

Entry	Author	Date	Location
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics	Luke Timmerman	12/15/11	Boston
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO	Luke Timmerman	12/14/11	San Diego
Agradis Takes Root, Illumina Cuts Back, Verenium Arranges Financing, & More San Diego Life Sciences News	Bruce V. Bigelow	10/27/11	San Diego
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease	Bruce V. Bigelow	10/25/11	San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine	Luke Timmerman	08/17/11	National
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund	Gregory T. Huang	08/11/11	Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs	Luke Timmerman	05/25/11	Boston
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
Proteostasis Adds Targets, Drugs From Harvard	Luke Timmerman	04/26/11	Boston
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News	Luke Timmerman	02/25/11	San Francisco
Avalon’s Kinsella Upbraids Big Pharma, Scripps Names Marletta to Succeed Lerner, CalciMedica Scores $6M, & More San Diego Life Science News	Bruce V. Bigelow	02/24/11	San Diego
Scripps Names UC Berkeley Chemist Marletta as New President	Luke Timmerman	02/21/11	San Diego
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News	Bruce V. Bigelow	02/03/11	San Diego
Scripps President Richard Lerner To Step Down, Be Replaced by Berkeley Chemist, Sources Say	Luke Timmerman	01/31/11	San Diego
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011	N. Anthony Coles	12/30/10	San Francisco
Ramius Buys Cypress Bio, Genoptix Reportedly Exploring Possible Sale, Anaphore Gets Japanese Partner, & More San Diego Life Sciences News	Bruce V. Bigelow	12/16/10	San Diego
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders	Luke Timmerman	12/13/10	San Diego
Pearl Therapeutics Beats $3B Lung Drug, Anacor’s Flat IPO, Medtronic Buys Ardian for $800M, & More Bay Area Life Sciences News	Luke Timmerman	12/03/10	San Francisco
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News	Erin Kutz	12/03/10	Boston
Receptos Hires New CEO, Former Facet Leader, as Rastetter Moves Upstairs	Luke Timmerman	12/02/10	San Diego
Accelerator’s East Coast Foray, Gates Foundation Bets on RSV Vaccine, UW Sues GE, & More Seattle-Area Life Sciences News	Luke Timmerman	12/02/10	Seattle
Optimer Seeks Fast Review of Drug for Intestinal Infection, Histogen Raises $10M, TSRI Shares its “Click” Chemistry in Deal with Massachusetts Biotech, & More San Diego Life Sciences News	Bruce V. Bigelow	12/02/10	San Diego
Heartland Reaps $20M, CloudBees Gathers $4M, Adimab Acquires $4M, & More Boston-Area Deals News	Rebecca Zacks	12/01/10	Boston
Aileron and Scripps Ink Deal	Ryan McBride	11/30/10	Boston
How To Keep Academic/Big Pharma Alliances from Going off the Rails	Scott Forrest	11/30/10	San Diego
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets	Luke Timmerman	10/26/10	San Diego
Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology	Luke Timmerman	10/14/10	San Diego
San Diego’s Mini-Cluster of Virtual Biotechs Without Labs on High Bluff Drive	Luke Timmerman	10/13/10	San Diego
Novartis-backed Genomics Institute Names Martin Seidel as New Director, Replacing Peter Schultz	Luke Timmerman	10/05/10	San Diego
NextBio Finds Profit at Intersection Between Public and Private Genomic Data	Luke Timmerman	09/28/10	San Francisco
Page 1 of 3	next page »